XTESO

Serial Number 97760212
606

Registration Progress

Application Filed
Jan 19, 2023
Under Examination
Jan 30, 2024
Approved for Publication
Dec 5, 2023
Published for Opposition
Dec 5, 2023
Registered

Trademark Image

XTESO

Basic Information

Serial Number
97760212
Filing Date
January 19, 2023
Published for Opposition
December 5, 2023
Abandonment Date
September 2, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 2, 2024
Classes
005

Rights Holder

SLAYBACK PHARMA LIMITED LIABILITY COMPANY

16
Address
301 Carnegie Center, Suite 303
Princeton, NJ 08540

Ownership History

SLAYBACK PHARMA LIMITED LIABILITY COMPANY

Original Applicant
16
Princeton, NJ

SLAYBACK PHARMA LIMITED LIABILITY COMPANY

Owner at Publication
16
Princeton, NJ

Legal Representation

Attorney
Maureen E. Kelly

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description
Sep 2, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 2, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jan 30, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 5, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2023 PUBO A PUBLISHED FOR OPPOSITION
Nov 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 30, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED
Oct 30, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED
Oct 30, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 30, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN
Oct 17, 2023 DOCK D ASSIGNED TO EXAMINER
Aug 18, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 18, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Hormonal preparation for medicinal use; Pharmaceutical preparations for the treatment of endocrine diseases and disorders; Pharmaceutical preparations for the treatment of hypogonadism

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...